Trang Trinh, PharmD, MPH

Associate Professor

Department of Clinical Pharmacy

+1 415 885-3817

Trang Trinh has extensive clinical and research training in infectious diseases pharmacoepidemiology. Currently, her research focuses on the epidemiology and clinical outcomes of multi-drug resistant bacterial infections. Through collaborations with the UCSF Medical Center antimicrobial stewardship program, Trang brings an analytical pharmacotherapy perspective to optimize antimicrobial use in patients with limited treatment options. She is especially interested in standardizing infectious disease study methodologies and leadership/change management to innovate appropriate antimicrobial prescribing strategies in the outpatient setting. In addition to her research focus, Trang also teaches epidemiology, study design, and infectious disease pharmacotherapy in the School of Pharmacy curriculum. She precepts and mentors pharmacy students and residents on their research projects.

Trang received her PharmD from the University of Maryland, School of Pharmacy. She completed residencies in Pharmacy Practice and Infectious Diseases Pharmacotherapy at the University of Florida Health Shands Hospital, followed by two years of fellowship in Infectious Diseases Outcomes Research at the Anti-Infective Research Laboratory at Wayne State University where she also received her MPH. Trang holds dual Board Certifications in Pharmacotherapy and Infectious Disease.

Publications:

International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections.

Infectious diseases and therapy

Zasowski EJ, Trinh TD, Claeys KC, Dryden M, Shlyapnikov S, Bassetti M, Carnelutti A, Khachatryan N, Kurup A, Pulido Cejudo A, Melo L, Cao B, Rybak MJ

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection.

Open forum infectious diseases

Zasowski EJ, Trinh TD, Claeys KC, Lagnf AM, Bhatia S, Klinker KP, Veve MP, Estrada SJ, Johns ST, Sawyer AJ, Huang V, LaFrance B, Levine DP, Kaye KS, Davis SL, Rybak MJ

Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant Staphylococcus aureus Bacteremia: STAPH Study.

Open forum infectious diseases

Alosaimy S, Lagnf AM, Morrisette T, Jorgensen SCJ, Trinh TD, Zasowski EJ, Scipione MR, Zhao JJ, Mynatt R, Herbin S, Dhar S, Chopra T, Janisse J, Rebold N, Pogue JM, Rybak MJ

Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.

Infection control and hospital epidemiology

Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB

Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Jorgensen SCJ, Zasowski EJ, Trinh TD, Lagnf AM, Bhatia S, Sabagha N, Abdul-Mutakabbir JC, Alosaimy S, Mynatt RP, Davis SL, Rybak MJ

Corrigendum to: The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Treated With Vancomycin.

Open forum infectious diseases

Zasowski EJ, Trinh TD, Atwan SM, Merzlyakova M, Langf AM, Bhatia S, Rybak MJ

Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with ß-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis.

Infectious diseases and therapy

Alosaimy S, Sabagha NL, Lagnf AM, Zasowski EJ, Morrisette T, Jorgensen SCJ, Trinh TD, Mynatt RP, Rybak MJ

Real-world experience with ceftolozane-tazobactam for multidrug-resistant gram-negative bacterial infections.

Antimicrobial agents and chemotherapy

Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Simon SP, Bhatia S, Melvin SM, Steed ME, Finch NA, Morrisette T, Estrada SJ, Rosenberg JR, Davis SL, Rybak MJ

Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-Avibactam.

Infectious diseases and therapy

Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Melvin SM, Simon SP, Rosenberg JR, Steed ME, Estrada SJ, Morrisette T, Davis SL, Rybak MJ

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections.

Open forum infectious diseases

Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Melvin SM, Steed ME, Simon SP, Estrada SJ, Morrisette T, Claeys KC, Rosenberg JR, Davis SL, Rybak MJ

A multicenter study of the real-world use of ceftaroline versus vancomycin for acute bacterial skin and skin structure infections.

Antimicrobial agents and chemotherapy

Trinh TD, Jorgensen SCJ, Zasowski EJ, Claeys KC, Lagnf AM, Estrada SJ, Delaportes DJ, Huang V, Klinker KP, Kaye KS, Davis SL, Rybak MJ

Parenteral Fosfomycin: A New Ally in the Fight Against Multidrug-Resistant Bacterial Pathogens.

Pharmacotherapy

Trinh TD, Smith JR, Rybak MJ

Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations.

Current infectious disease reports

Ho S, Nguyen L, Trinh T, MacDougall C

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus.

Infectious diseases and therapy

Claeys KC, Zasowski EJ, Trinh TD, Casapao AM, Pogue JM, Bhatia N, Mynatt RP, Wilson SS, Arthur C, Welch R, Sherwin R, Hafeez W, Levine DP, Kaye KS, Delgado G, Giuliano CA, Takla R, Rieck C, Johnson LB, Murray KP, Gordon J, Reyes K, Hartman P, Davis SL, Rybak MJ